Theralase Technologies Inc. (TLT.V)


TSXV - TSXV Delayed Price. Currency in CAD
0.38+0.00 (+1.32%)
As of 11:55 AM EDT. Market open.
People also watch:
PHM.VZMS.VSBM.VCXV.VKEK.V
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.40
Prev Close0.38
Bid0.38 x
Ask0.39 x
Day's Range0.38 - 0.40
52wk Range0.27 - 0.45
1y Target EstN/A
Market Cap41.21M
P/E Ratio (ttm)-7.86
Beta-1.64
Volume28,855
Avg Vol (3m)120,361
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Theralase Technologies, Inc. :TLT-CA: Earnings Analysis: Q2, 2016 By the Numbers : September 13, 2016
    Capital Cube15 days ago

    Theralase Technologies, Inc. :TLT-CA: Earnings Analysis: Q2, 2016 By the Numbers : September 13, 2016

    Categories: Yahoo Finance Get free summary analysis Theralase Technologies, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Theralase Technologies, Inc. – Pyng Medical Corp., Verisante Technology, Inc., Annidis Corporation, Medx Health Corp., Cynosure, Inc. Class A, CRH Medical Corporation and Ventripoint Diagnostics Ltd. (PYT-CA, VRS-CA, ... Read more (Read more...)

  • Accesswire16 days ago

    Theralase to Present at Global Investment Conference

    TORONTO, ON / ACCESSWIRE / September 12, 2016 / Theralase Technologies Inc. (" Theralase® " or the " Company ") ( TSX-V: TLT ) ( OTC: TLTFF ), a leading biotech company focused on the ...

  • PR Newswire22 days ago

    MicroCap Review Magazine Fall 2016 Issue Now Available

    LOS ANGELES, Sept. 6, 2016 /PRNewswire/ -- SNN Incorporated, a global multimedia financial news and publishing company focused on the MicroCap stock market, and publisher of the MicroCap Review Magazine, ...